101 related articles for article (PubMed ID: 16800851)
1. Multiple promoter elements required for leukemia inhibitory factor-stimulated M2 muscarinic acetylcholine receptor promoter activity.
Laszlo GS; Rosoff ML; Amieux PS; Nathanson NM
J Neurochem; 2006 Aug; 98(4):1302-15. PubMed ID: 16800851
[TBL] [Abstract][Full Text] [Related]
2. The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat binding element.
Tomida M; Saito T
Oncogene; 2004 Jan; 23(3):679-86. PubMed ID: 14647442
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involvement of STAT proteins.
Lecomte MJ; Basseville M; Landon F; Karpov V; Fauquet M
J Neurochem; 1998 Mar; 70(3):971-82. PubMed ID: 9489716
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells.
Sekkaï D; Gruel G; Herry M; Moucadel V; Constantinescu SN; Albagli O; Tronik-Le Roux D; Vainchenker W; Bennaceur-Griscelli A
Stem Cells; 2005; 23(10):1634-42. PubMed ID: 16099994
[TBL] [Abstract][Full Text] [Related]
5. Multiple promoters drive tissue-specific expression of the human M muscarinic acetylcholine receptor gene.
Krejci A; Bruce AW; Dolezal V; Tucek S; Buckley NJ
J Neurochem; 2004 Oct; 91(1):88-98. PubMed ID: 15379890
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
7. The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter.
Hogan JC; Stephens JM
Biochem Biophys Res Commun; 2001 Sep; 287(2):484-92. PubMed ID: 11554754
[TBL] [Abstract][Full Text] [Related]
8. Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells.
Göllner G; Bug G; Rupilius B; Peschel C; Huber C; Derigs HG
Cytokine; 1999 Sep; 11(9):656-63. PubMed ID: 10479401
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6.
Börner C; Kraus J; Schröder H; Ammer H; Höllt V
Mol Pharmacol; 2004 Dec; 66(6):1719-26. PubMed ID: 15448191
[TBL] [Abstract][Full Text] [Related]
10. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
11. The LIF response element of the alpha 2 macroglobulin gene confers LIF-induced transcriptional activation in embryonal stem cells.
Hocke GM; Cui MZ; Fey GH
Cytokine; 1995 Aug; 7(6):491-502. PubMed ID: 8580364
[TBL] [Abstract][Full Text] [Related]
12. Retrograde activation of STAT3 by leukemia inhibitory factor in sympathetic neurons.
O'Brien JJ; Nathanson NM
J Neurochem; 2007 Oct; 103(1):288-302. PubMed ID: 17608645
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the interferon-inducible PKR kinase gene: the KCS element is a constitutive promoter element that functions in concert with the interferon-stimulated response element.
Ward SV; Samuel CE
Virology; 2002 Apr; 296(1):136-46. PubMed ID: 12036325
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of interferon-gamma mediated down-regulation of interleukin-10 gene expression.
Schaefer A; Unterberger C; Frankenberger M; Lohrum M; Staples KJ; Werner T; Stunnenberg H; Ziegler-Heitbrock L
Mol Immunol; 2009 Apr; 46(7):1351-9. PubMed ID: 19124156
[TBL] [Abstract][Full Text] [Related]
15. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions.
Mynard V; Guignat L; Devin-Leclerc J; Bertagna X; Catelli MG
Endocrinology; 2002 Oct; 143(10):3916-24. PubMed ID: 12239103
[TBL] [Abstract][Full Text] [Related]
17. Effects of leptin and leukemia inhibitory factor on preimplantation development and STAT3 signaling of mouse embryos in vitro.
Fedorcsák P; Storeng R
Biol Reprod; 2003 Nov; 69(5):1531-8. PubMed ID: 12826573
[TBL] [Abstract][Full Text] [Related]
18. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
Bartoe JL; Nathanson NM
Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
[TBL] [Abstract][Full Text] [Related]
19. Structure of the bovine VASAP-60/PRKCSH gene, functional analysis of the promoter, and gene expression analysis.
Brûlé S; Sayasith K; Sirois J; Silversides DW; Lussier JG
Gene; 2007 Apr; 391(1-2):63-75. PubMed ID: 17250974
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
